Korean J Gastroenterol.  2011 Oct;58(4):169-170. 10.4166/kjg.2011.58.4.169.

Are Proton Pump Inhibitors Effective in Asthmatics with Gastroesophageal Reflux Disease?

• Kim JH

• KMID: 1718423
• DOI: http://doi.org/10.4166/kjg.2011.58.4.169

Abstract

No abstract available.

MeSH Terms

Asthma/*complications
Female
Gastroesophageal Reflux/*drug therapy
Humans
Male
Proton Pump Inhibitors/*therapeutic use

Reference

References

1. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006; 101:1900–1920.

2. Lee BE, Kim GH. Diagnosis of gastroesophageal reflux disease: esophageal and extraesophageal manifestations. Korean J Med. 2010; 78:145–154.

3. Mays EE. Intrinsic asthma in adults. Association with gastroesophageal reflux. JAMA. 1976; 236:2626–2628.

4. Gurski RR, da Rosa AR, do Valle E, de Borba MA, Valiati AA. Extraesophageal manifestations of gastroesophageal reflux disease. J Bras Pneumol. 2006; 32:150–160.

5. Harding SM, Guzzo MR, Richter JE. 24-h esophageal pH testing in asthmatics: respiratory symptom correlation with esophageal acid events. Chest. 1999; 115:654–659.

6. Sontag SJ, O'Connell S, Khandelwal S, et al. Most asthmatics have gastroesophageal reflux with or without bronchodilator therapy. Gastroenterology. 1990; 99:613–620.

7. Lee YB, Lim JH, Choi YJ, et al. Effects of proton pump inhibitors in asthmatics with gastroesophageal reflux disease. Korean J Gastroenterol. 2011; 58:178–183.

8. Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008; 31:143–178.

9. Littner MR, Leung FW, Ballard ED 2nd, Huang B, Samra NK. Lansoprazole Asthma Study Group. Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms. Chest. 2005; 128:1128–1135.